Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 63 entries
Sorted by: Best Match Show Resources per page
Some Observations on the Value of Novasurol in Cardiac Dropsy.

The Indian medical gazette

Mudaliar GN.
PMID: 29011642
Ind Med Gaz. 1928 Jun;63(6):334.

No abstract available.

Cite
Mudaliar GN. Some Observations on the Value of Novasurol in Cardiac Dropsy. Ind Med Gaz. 1928;63(6):334
Mudaliar, G. N. (1928). Some Observations on the Value of Novasurol in Cardiac Dropsy. The Indian medical gazette, 63(6), 334.
Mudaliar, G Narayanaswamy. "Some Observations on the Value of Novasurol in Cardiac Dropsy." The Indian medical gazette vol. 63,6 (1928): 334.
Mudaliar GN. Some Observations on the Value of Novasurol in Cardiac Dropsy. Ind Med Gaz. 1928 Jun;63(6):334. PMID: 29011642; PMCID: PMC5235770.
Copy Download .nbib Format: NLM
Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity.

Diabetology & metabolic syndrome

Bhansali S, Dutta P, Yadav MK, Jain A, Mudaliar S, Hawkins M, Kurpad AV, Pahwa D, Yadav AK, Sharma RR, Jha V, Marwaha N, Bhansali S, Bhansali A.
PMID: 28690682
Diabetol Metab Syndr. 2017 Jul 04;9:50. doi: 10.1186/s13098-017-0248-7. eCollection 2017.

BACKGROUND: Insulin resistance and insulin deficiency are the cardinal defects in the pathogenesis of type 2 diabetes mellitus (T2DM). Despite the plethora of anti-diabetic medications, drugs specifically targeting the β-cells are still desired. Stem cell therapy has emerged as...

Cite
Bhansali S, Dutta P, Yadav MK, et al. Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity. Diabetol Metab Syndr. 2017;9:50doi: 10.1186/s13098-017-0248-7.
Bhansali, S., Dutta, P., Yadav, M. K., Jain, A., Mudaliar, S., Hawkins, M., Kurpad, A. V., Pahwa, D., Yadav, A. K., Sharma, R. R., Jha, V., Marwaha, N., Bhansali, S., & Bhansali, A. (2017). Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity. Diabetology & metabolic syndrome, 950. https://doi.org/10.1186/s13098-017-0248-7
Bhansali, Shobhit, et al. "Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity." Diabetology & metabolic syndrome vol. 9 (2017): 50. doi: https://doi.org/10.1186/s13098-017-0248-7
Bhansali S, Dutta P, Yadav MK, Jain A, Mudaliar S, Hawkins M, Kurpad AV, Pahwa D, Yadav AK, Sharma RR, Jha V, Marwaha N, Bhansali S, Bhansali A. Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity. Diabetol Metab Syndr. 2017 Jul 04;9:50. doi: 10.1186/s13098-017-0248-7. eCollection 2017. PMID: 28690682; PMCID: PMC5496640.
Copy Download .nbib Format: NLM
Chaos syndrome.

BJR case reports

Mudaliyar US, Sreedhar S.
PMID: 30363271
BJR Case Rep. 2017 Mar 14;3(3):20160046. doi: 10.1259/bjrcr.20160046. eCollection 2017.

Congenital high airway obstruction syndrome (CHAOS) is the obstruction of the foetal upper airways, which may be partial or complete. It is usually incompatible with life. Prenatal recognition of the disease is quite important. We report here a case...

Cite
Mudaliyar US, Sreedhar S. Chaos syndrome. BJR Case Rep. 2017;3(3):20160046doi: 10.1259/bjrcr.20160046.
Mudaliyar, U. S., & Sreedhar, S. (2017). Chaos syndrome. BJR case reports, 3(3), 20160046. https://doi.org/10.1259/bjrcr.20160046
Mudaliyar, Umesh Shriniwas, and Sreedhar, Sneha. "Chaos syndrome." BJR case reports vol. 3,3 (2017): 20160046. doi: https://doi.org/10.1259/bjrcr.20160046
Mudaliyar US, Sreedhar S. Chaos syndrome. BJR Case Rep. 2017 Mar 14;3(3):20160046. doi: 10.1259/bjrcr.20160046. eCollection 2017. PMID: 30363271; PMCID: PMC6159205.
Copy Download .nbib Format: NLM
Comparison of Hematoxylin and Eosin Stain with Modified Gallego's Stain for Differentiating Mineralized Components in Ossifying Fibroma, Cemento-ossifying Fibroma, and Cementifying Fibroma.

Journal of microscopy and ultrastructure

Dhouskar S, Tamgadge S, Tamgadge A, Periera T, Mudaliar U, Pillai A.
PMID: 31548923
J Microsc Ultrastruct. 2019 Jul-Sep;7(3):124-129. doi: 10.4103/JMAU.JMAU_2_19.

OBJECTIVE: The nature of calcifications in fibro-osseous lesions is difficult to differentiate under hematoxylin and eosin (H and E) stain and could be misleading. Special stains could be used. Modified Gallego's stain is a differential stain for hard tissues,...

Cite
Dhouskar S, Tamgadge S, Tamgadge A, et al. Comparison of Hematoxylin and Eosin Stain with Modified Gallego's Stain for Differentiating Mineralized Components in Ossifying Fibroma, Cemento-ossifying Fibroma, and Cementifying Fibroma. J Microsc Ultrastruct. 2019;7(3):124-129doi: 10.4103/JMAU.JMAU_2_19.
Dhouskar, S., Tamgadge, S., Tamgadge, A., Periera, T., Mudaliar, U., & Pillai, A. (2019). Comparison of Hematoxylin and Eosin Stain with Modified Gallego's Stain for Differentiating Mineralized Components in Ossifying Fibroma, Cemento-ossifying Fibroma, and Cementifying Fibroma. Journal of microscopy and ultrastructure, 7(3), 124-129. https://doi.org/10.4103/JMAU.JMAU_2_19
Dhouskar, Snehal, et al. "Comparison of Hematoxylin and Eosin Stain with Modified Gallego's Stain for Differentiating Mineralized Components in Ossifying Fibroma, Cemento-ossifying Fibroma, and Cementifying Fibroma." Journal of microscopy and ultrastructure vol. 7,3 (2019): 124-129. doi: https://doi.org/10.4103/JMAU.JMAU_2_19
Dhouskar S, Tamgadge S, Tamgadge A, Periera T, Mudaliar U, Pillai A. Comparison of Hematoxylin and Eosin Stain with Modified Gallego's Stain for Differentiating Mineralized Components in Ossifying Fibroma, Cemento-ossifying Fibroma, and Cementifying Fibroma. J Microsc Ultrastruct. 2019 Jul-Sep;7(3):124-129. doi: 10.4103/JMAU.JMAU_2_19. PMID: 31548923; PMCID: PMC6753700.
Copy Download .nbib Format: NLM
Effects of powdered rifampin and vancomycin solutions on biofilm production of .

Journal of clinical orthopaedics and trauma

Douthit C, Gudenkauf B, Hamood A, Mudaliar N, Caroom C, Jenkins M.
PMID: 31992930
J Clin Orthop Trauma. 2020 Feb;11:S113-S117. doi: 10.1016/j.jcot.2019.10.002. Epub 2019 Oct 13.

PURPOSE: Hardware infections in orthopedic surgery, specifically those involving biofilm producing bacteria, are troublesome and are highly resistant to systemic antibiotics. The purpose of this study was to demonstrate the power of rifampin and vancomycin solutions in inhibiting as...

Cite
Douthit C, Gudenkauf B, Hamood A, et al. Effects of powdered rifampin and vancomycin solutions on biofilm production of . J Clin Orthop Trauma. 2019;11:S113-S117doi: 10.1016/j.jcot.2019.10.002.
Douthit, C., Gudenkauf, B., Hamood, A., Mudaliar, N., Caroom, C., & Jenkins, M. (2020). Effects of powdered rifampin and vancomycin solutions on biofilm production of . Journal of clinical orthopaedics and trauma, 11S113-S117. https://doi.org/10.1016/j.jcot.2019.10.002
Douthit, Christian, et al. "Effects of powdered rifampin and vancomycin solutions on biofilm production of ." Journal of clinical orthopaedics and trauma vol. 11 (2020): S113-S117. doi: https://doi.org/10.1016/j.jcot.2019.10.002
Douthit C, Gudenkauf B, Hamood A, Mudaliar N, Caroom C, Jenkins M. Effects of powdered rifampin and vancomycin solutions on biofilm production of . J Clin Orthop Trauma. 2020 Feb;11:S113-S117. doi: 10.1016/j.jcot.2019.10.002. Epub 2019 Oct 13. PMID: 31992930; PMCID: PMC6977531.
Copy Download .nbib Format: NLM
Integrating cardioprotective glucose-lowering medications into clinical practice.

Cardiovascular endocrinology & metabolism

Mudaliar S.
PMID: 31646275
Cardiovasc Endocrinol Metab. 2018 Feb 14;7(1):24-27. doi: 10.1097/XCE.0000000000000142. eCollection 2018 Mar.

Patients with type 2 diabetes suffer from both microvascular and macrovascular complications. Optimal glycemic control is well known to reduce the microvascular complications of retinopathy, nephropathy, and neuropathy. However, despite having multiple classes of antidiabetes medications, we have not...

Cite
Mudaliar S. Integrating cardioprotective glucose-lowering medications into clinical practice. Cardiovasc Endocrinol Metab. 2018;7(1):24-27doi: 10.1097/XCE.0000000000000142.
Mudaliar, S. (2018). Integrating cardioprotective glucose-lowering medications into clinical practice. Cardiovascular endocrinology & metabolism, 7(1), 24-27. https://doi.org/10.1097/XCE.0000000000000142
Mudaliar, Sunder. "Integrating cardioprotective glucose-lowering medications into clinical practice." Cardiovascular endocrinology & metabolism vol. 7,1 (2018): 24-27. doi: https://doi.org/10.1097/XCE.0000000000000142
Mudaliar S. Integrating cardioprotective glucose-lowering medications into clinical practice. Cardiovasc Endocrinol Metab. 2018 Feb 14;7(1):24-27. doi: 10.1097/XCE.0000000000000142. eCollection 2018 Mar. PMID: 31646275; PMCID: PMC6739882.
Copy Download .nbib Format: NLM
Immunohistochemical Expression of Myofibroblasts Using Alpha-smooth Muscle Actin (SMA) to Assess the Aggressive Potential of Various Clinical Subtypes of Ameloblastoma.

Journal of microscopy and ultrastructure

Mudaliar U, Tamgadge A, Tamgadge S, Pereira T, Dhouskar S, Rajhans S, Salunke G.
PMID: 31548924
J Microsc Ultrastruct. 2019 Jul-Sep;7(3):130-135. doi: 10.4103/JMAU.JMAU_10_19.

OBJECTIVE: Ameloblastoma is a rare odontogenic neoplasm with high recurrence rates if improperly treated. If left untreated (or is treated inadequately), it can cause substantial morbidity, disfigurement, and even death. Hence, there is a need to explore the stromal...

Cite
Mudaliar U, Tamgadge A, Tamgadge S, et al. Immunohistochemical Expression of Myofibroblasts Using Alpha-smooth Muscle Actin (SMA) to Assess the Aggressive Potential of Various Clinical Subtypes of Ameloblastoma. J Microsc Ultrastruct. 2019;7(3):130-135doi: 10.4103/JMAU.JMAU_10_19.
Mudaliar, U., Tamgadge, A., Tamgadge, S., Pereira, T., Dhouskar, S., Rajhans, S., & Salunke, G. (2019). Immunohistochemical Expression of Myofibroblasts Using Alpha-smooth Muscle Actin (SMA) to Assess the Aggressive Potential of Various Clinical Subtypes of Ameloblastoma. Journal of microscopy and ultrastructure, 7(3), 130-135. https://doi.org/10.4103/JMAU.JMAU_10_19
Mudaliar, Uma, et al. "Immunohistochemical Expression of Myofibroblasts Using Alpha-smooth Muscle Actin (SMA) to Assess the Aggressive Potential of Various Clinical Subtypes of Ameloblastoma." Journal of microscopy and ultrastructure vol. 7,3 (2019): 130-135. doi: https://doi.org/10.4103/JMAU.JMAU_10_19
Mudaliar U, Tamgadge A, Tamgadge S, Pereira T, Dhouskar S, Rajhans S, Salunke G. Immunohistochemical Expression of Myofibroblasts Using Alpha-smooth Muscle Actin (SMA) to Assess the Aggressive Potential of Various Clinical Subtypes of Ameloblastoma. J Microsc Ultrastruct. 2019 Jul-Sep;7(3):130-135. doi: 10.4103/JMAU.JMAU_10_19. PMID: 31548924; PMCID: PMC6753696.
Copy Download .nbib Format: NLM
Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.

Journal of laboratory physicians

Singh PK, Kulsum U, Rufai SB, Mudliar SR, Singh S.
PMID: 32884216
J Lab Physicians. 2020 Aug;12(2):154-160. doi: 10.1055/s-0040-1715790. Epub 2020 Sep 01.

No abstract available.

Cite
Singh PK, Kulsum U, Rufai SB, et al. Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. J Lab Physicians. 2020;12(2):154-160doi: 10.1055/s-0040-1715790.
Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of laboratory physicians, 12(2), 154-160. https://doi.org/10.1055/s-0040-1715790
Singh, Praveen Kumar, et al. "Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development." Journal of laboratory physicians vol. 12,2 (2020): 154-160. doi: https://doi.org/10.1055/s-0040-1715790
Singh PK, Kulsum U, Rufai SB, Mudliar SR, Singh S. Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. J Lab Physicians. 2020 Aug;12(2):154-160. doi: 10.1055/s-0040-1715790. Epub 2020 Sep 01. PMID: 32884216; PMCID: PMC7462717.
Copy Download .nbib Format: NLM
Strawberry skull in Edwards syndrome.

BJR case reports

Mudaliyar US, Mudaliyar SU.
PMID: 30363185
BJR Case Rep. 2017 Jun 10;3(4):20170045. doi: 10.1259/bjrcr.20170045. eCollection 2017.

The trisomy 18 syndrome, also known as Edwards syndrome, is the second most common disorder after trisomy 21 (Down's syndrome). It is a chromosomal disorder due to the presence of an extra chromosome 18, which could be either full,...

Cite
Mudaliyar US, Mudaliyar SU. Strawberry skull in Edwards syndrome. BJR Case Rep. 2017;3(4):20170045doi: 10.1259/bjrcr.20170045.
Mudaliyar, U. S., & Mudaliyar, S. U. (2017). Strawberry skull in Edwards syndrome. BJR case reports, 3(4), 20170045. https://doi.org/10.1259/bjrcr.20170045
Mudaliyar, Umesh Shriniwas, and Mudaliyar, Sneha Umesh. "Strawberry skull in Edwards syndrome." BJR case reports vol. 3,4 (2017): 20170045. doi: https://doi.org/10.1259/bjrcr.20170045
Mudaliyar US, Mudaliyar SU. Strawberry skull in Edwards syndrome. BJR Case Rep. 2017 Jun 10;3(4):20170045. doi: 10.1259/bjrcr.20170045. eCollection 2017. PMID: 30363185; PMCID: PMC6159170.
Copy Download .nbib Format: NLM
Aphonia after Quinine Administration.

The Indian medical gazette

Mudaliar SAJ.
PMID: 29008800
Ind Med Gaz. 1930 May;65(5):298.

No abstract available.

Cite
Mudaliar SAJ. Aphonia after Quinine Administration. Ind Med Gaz. 1930;65(5):298
Mudaliar, S. A. J. (1930). Aphonia after Quinine Administration. The Indian medical gazette, 65(5), 298.
Mudaliar, S A Jegaraya. "Aphonia after Quinine Administration." The Indian medical gazette vol. 65,5 (1930): 298.
Mudaliar SAJ. Aphonia after Quinine Administration. Ind Med Gaz. 1930 May;65(5):298. PMID: 29008800; PMCID: PMC5157385.
Copy Download .nbib Format: NLM
Three Interesting Cases.

The Indian medical gazette

Mudaliar KSA.
PMID: 29010147
Ind Med Gaz. 1931 Jan;66(1):29.

No abstract available.

Cite
Mudaliar KSA. Three Interesting Cases. Ind Med Gaz. 1931;66(1):29
Mudaliar, K. S. A. (1931). Three Interesting Cases. The Indian medical gazette, 66(1), 29.
Mudaliar, K S Appu. "Three Interesting Cases." The Indian medical gazette vol. 66,1 (1931): 29.
Mudaliar KSA. Three Interesting Cases. Ind Med Gaz. 1931 Jan;66(1):29. PMID: 29010147; PMCID: PMC5185977.
Copy Download .nbib Format: NLM
The Treatment of Puerperal Eclampsia, with Notes on 220 Cases of Puerperal Eclampsia Treated at the Government Hospital for Women and Children, Madras, during the Years January 1922 to July 1926.

The Indian medical gazette

Hingston CAF, Mudaliar AL.
PMID: 29010532
Ind Med Gaz. 1927 Apr;62(4):179-182.

No abstract available.

Cite
Hingston CAF, Mudaliar AL. The Treatment of Puerperal Eclampsia, with Notes on 220 Cases of Puerperal Eclampsia Treated at the Government Hospital for Women and Children, Madras, during the Years January 1922 to July 1926. Ind Med Gaz. 1927;62(4):179-182
Hingston, C. A. F., & Mudaliar, A. L. (1927). The Treatment of Puerperal Eclampsia, with Notes on 220 Cases of Puerperal Eclampsia Treated at the Government Hospital for Women and Children, Madras, during the Years January 1922 to July 1926. The Indian medical gazette, 62(4), 179-182.
Hingston, C A F, and Mudaliar, A Lakshmanaswami. "The Treatment of Puerperal Eclampsia, with Notes on 220 Cases of Puerperal Eclampsia Treated at the Government Hospital for Women and Children, Madras, during the Years January 1922 to July 1926." The Indian medical gazette vol. 62,4 (1927): 179-182.
Hingston CAF, Mudaliar AL. The Treatment of Puerperal Eclampsia, with Notes on 220 Cases of Puerperal Eclampsia Treated at the Government Hospital for Women and Children, Madras, during the Years January 1922 to July 1926. Ind Med Gaz. 1927 Apr;62(4):179-182. PMID: 29010532; PMCID: PMC5197538.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 63 entries